1. Newly diagnosed suspicious International Federation of Gynecology and Obstetrics (FIGO) stage III A or greater ovarian, fallopian tube, or primary peritoneal cancer
2. Age between 18 and 80 years
3. Estimated life expectancy of at least 4 weeks 4. Signed informed consent
You may not be if
1. Any previous cancer in the last 5 years
2. Previous chemotherapy or target treatments 3. Diagnosis of synchronous tumors
3. Pregnancy or breastfeeding
4. Missed informed consent
Clareo Health | SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS
